APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Custom Adeno-Associated Virus (AAV) Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Custom Adeno-Associated Virus (AAV) Services Industry Growth and Trends Forecast to 2032

Report ID 17410794012 May 2026122 pages

Choose your research edition.

Industry ResearchCustom Adeno-Associated Virus (AAV) Services Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Adeno-Associated Virus (AAV) Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Custom Adeno-Associated Virus (AAV) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Adeno-Associated Virus (AAV) Services Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Adeno-Associated Virus (AAV) Services Market Analysis and Forecast 2026-2032225 pages · $4,950 USD

Market perspective

According to APO Research, the global Custom Adeno-Associated Virus (AAV) Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Custom Adeno-Associated Virus (AAV) Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Custom Adeno-Associated Virus (AAV) Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Adeno-Associated Virus (AAV) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Custom Adeno-Associated Virus (AAV) Services market include Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, SK pharmteco, Oxford Biomedica, AGC Biologics（MolMed） and Gene Universal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Custom Adeno-Associated Virus (AAV) Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Custom Adeno-Associated Virus (AAV) Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Custom Adeno-Associated Virus (AAV) Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Custom Adeno-Associated Virus (AAV) Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Custom Adeno-Associated Virus (AAV) Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Custom Adeno-Associated Virus (AAV) Services Market by Company

Thermo Fisher Scientific

Lonza

Catalent

Charles River

Merck

SK pharmteco

Oxford Biomedica

AGC Biologics（MolMed）

Gene Universal

Polyplus (Sartorius)

CCRM

FUJIFILM Diosynth Biotechnologies

Biovian

Miltenyi Bioindustry

Aldevron

Takara Bio

Yposkesi

Genezen

Exthera

GenScript ProBio

EurekaBio

Obio Technology

GeneSail Biotech

VectorBuilder

WuXi ATU

Ubrigene

Porton Biologics

Pharmaron

PackGene Biotechnology

Custom Adeno-Associated Virus (AAV) Services Segment by Type

Adherent Culture

Suspension Culture

Custom Adeno-Associated Virus (AAV) Services Segment by Application

Vaccine Development

Gene Therapy

Academic Scientific Research Institution

Others

Custom Adeno-Associated Virus (AAV) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Adeno-Associated Virus (AAV) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Adeno-Associated Virus (AAV) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Adeno-Associated Virus (AAV) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Custom Adeno-Associated Virus (AAV) Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Custom Adeno-Associated Virus (AAV) Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region (2021-2026) Table 4. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region (2027-2032) Table 6. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Custom Adeno-Associated Virus (AAV) Services Market Size Share by Type (2021-2026) Table 9. Global Custom Adeno-Associated Virus (AAV) Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Custom Adeno-Associated Virus (AAV) Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Custom Adeno-Associated Virus (AAV) Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Custom Adeno-Associated Virus (AAV) Services Market Size Share by Application (2021-2026) Table 24. Global Custom Adeno-Associated Virus (AAV) Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Custom Adeno-Associated Virus (AAV) Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Custom Adeno-Associated Virus (AAV) Services Industry Trends Table 37. Custom Adeno-Associated Virus (AAV) Services Industry Drivers Table 38. Custom Adeno-Associated Virus (AAV) Services Industry Opportunities and Challenges Table 39. Custom Adeno-Associated Virus (AAV) Services Industry Restraints Table 40. Global Custom Adeno-Associated Virus (AAV) Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Custom Adeno-Associated Virus (AAV) Services Revenue Market Share by Company (2021-2026) Table 42. Global Custom Adeno-Associated Virus (AAV) Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Custom Adeno-Associated Virus (AAV) Services Key Company Headquarters & Area Served Table 44. Global Custom Adeno-Associated Virus (AAV) Services Company, Product Type & Application Table 45. Global Custom Adeno-Associated Virus (AAV) Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Custom Adeno-Associated Virus (AAV) Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 52. Thermo Fisher Scientific Recent Development Table 53. Lonza Company Information Table 54. Lonza Business Overview Table 55. Lonza Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 57. Lonza Recent Development Table 58. Catalent Company Information Table 59. Catalent Business Overview Table 60. Catalent Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 62. Catalent Recent Development Table 63. Charles River Company Information Table 64. Charles River Business Overview Table 65. Charles River Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 67. Charles River Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 72. Merck Recent Development Table 73. SK pharmteco Company Information Table 74. SK pharmteco Business Overview Table 75. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 77. SK pharmteco Recent Development Table 78. Oxford Biomedica Company Information Table 79. Oxford Biomedica Business Overview Table 80. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 82. Oxford Biomedica Recent Development Table 83. AGC Biologics（MolMed） Company Information Table 84. AGC Biologics（MolMed） Business Overview Table 85. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 87. AGC Biologics（MolMed） Recent Development Table 88. Gene Universal Company Information Table 89. Gene Universal Business Overview Table 90. Gene Universal Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 92. Gene Universal Recent Development Table 93. Polyplus (Sartorius) Company Information Table 94. Polyplus (Sartorius) Business Overview Table 95. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 97. Polyplus (Sartorius) Recent Development Table 98. CCRM Company Information Table 99. CCRM Business Overview Table 100. CCRM Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 102. CCRM Recent Development Table 103. FUJIFILM Diosynth Biotechnologies Company Information Table 104. FUJIFILM Diosynth Biotechnologies Business Overview Table 105. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 107. FUJIFILM Diosynth Biotechnologies Recent Development Table 108. Biovian Company Information Table 109. Biovian Business Overview Table 110. Biovian Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 112. Biovian Recent Development Table 113. Miltenyi Bioindustry Company Information Table 114. Miltenyi Bioindustry Business Overview Table 115. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 117. Miltenyi Bioindustry Recent Development Table 118. Aldevron Company Information Table 119. Aldevron Business Overview Table 120. Aldevron Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 122. Aldevron Recent Development Table 123. Takara Bio Company Information Table 124. Takara Bio Business Overview Table 125. Takara Bio Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 127. Takara Bio Recent Development Table 128. Yposkesi Company Information Table 129. Yposkesi Business Overview Table 130. Yposkesi Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 132. Yposkesi Recent Development Table 133. Genezen Company Information Table 134. Genezen Business Overview Table 135. Genezen Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 137. Genezen Recent Development Table 138. Exthera Company Information Table 139. Exthera Business Overview Table 140. Exthera Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 142. Exthera Recent Development Table 143. GenScript ProBio Company Information Table 144. GenScript ProBio Business Overview Table 145. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 147. GenScript ProBio Recent Development Table 148. EurekaBio Company Information Table 149. EurekaBio Business Overview Table 150. EurekaBio Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 152. EurekaBio Recent Development Table 153. Obio Technology Company Information Table 154. Obio Technology Business Overview Table 155. Obio Technology Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 157. Obio Technology Recent Development Table 158. GeneSail Biotech Company Information Table 159. GeneSail Biotech Business Overview Table 160. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 162. GeneSail Biotech Recent Development Table 163. VectorBuilder Company Information Table 164. VectorBuilder Business Overview Table 165. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 167. VectorBuilder Recent Development Table 168. WuXi ATU Company Information Table 169. WuXi ATU Business Overview Table 170. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 172. WuXi ATU Recent Development Table 173. Ubrigene Company Information Table 174. Ubrigene Business Overview Table 175. Ubrigene Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 177. Ubrigene Recent Development Table 178. Porton Biologics Company Information Table 179. Porton Biologics Business Overview Table 180. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 182. Porton Biologics Recent Development Table 183. Pharmaron Company Information Table 184. Pharmaron Business Overview Table 185. Pharmaron Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 187. Pharmaron Recent Development Table 188. PackGene Biotechnology Company Information Table 189. PackGene Biotechnology Business Overview Table 190. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 191. PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio Table 192. PackGene Biotechnology Recent Development Table 193. North America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. North America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 195. North America Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2026) Table 196. North America Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. North America Custom Adeno-Associated Virus (AAV) Services Market Share Forecast by Country (2027-2032) Table 198. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Europe Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 200. Europe Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2026) Table 201. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Europe Custom Adeno-Associated Virus (AAV) Services Market Share Forecast by Country (2027-2032) Table 203. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 205. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2026) Table 206. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Share Forecast by Country (2027-2032) Table 208. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 210. Latin America Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2026) Table 211. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Latin America Custom Adeno-Associated Virus (AAV) Services Market Share Forecast by Country (2027-2032) Table 213. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026) & (US$ Million) Table 215. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2026) Table 216. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Share Forecast by Country (2027-2032) Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Custom Adeno-Associated Virus (AAV) Services Product Image Figure 3. Global Custom Adeno-Associated Virus (AAV) Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region: 2025 VS 2032 Figure 6. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Region (2021-2032) Figure 7. North America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Adherent Culture Image Figure 13. Global Adherent Culture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Suspension Culture Image Figure 15. Global Suspension Culture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Custom Adeno-Associated Virus (AAV) Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Type 2025 VS 2032 Figure 18. North America Custom Adeno-Associated Virus (AAV) Services Market Size Share by Type (2021-2032) Figure 19. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Share by Type (2021-2032) Figure 21. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Share by Type (2021-2032) Figure 23. Vaccine Development Image Figure 24. Global Vaccine Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Gene Therapy Image Figure 26. Global Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Academic Scientific Research Institution Image Figure 28. Global Academic Scientific Research Institution Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Custom Adeno-Associated Virus (AAV) Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Custom Adeno-Associated Virus (AAV) Services Market Share by Application 2025 VS 2032 Figure 33. North America Custom Adeno-Associated Virus (AAV) Services Market Size Share by Application (2021-2032) Figure 34. Europe Custom Adeno-Associated Virus (AAV) Services Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Share by Application (2021-2032) Figure 36. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Custom Adeno-Associated Virus (AAV) Services Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Custom Adeno-Associated Virus (AAV) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Custom Adeno-Associated Virus (AAV) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 43. Europe Custom Adeno-Associated Virus (AAV) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Custom Adeno-Associated Virus (AAV) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 46. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 49. Latin America Custom Adeno-Associated Virus (AAV) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Custom Adeno-Associated Virus (AAV) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 52. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Adherent Culture
  • Suspension Culture
Applications
  • Vaccine Development
  • Gene Therapy
  • Academic Scientific Research Institution
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Lonza
  • Catalent
  • Charles River
  • Merck
  • SK pharmteco
  • Oxford Biomedica
  • AGC Biologics（MolMed）
  • Gene Universal
  • Polyplus (Sartorius)
  • CCRM
  • FUJIFILM Diosynth Biotechnologies
  • Biovian
  • Miltenyi Bioindustry
  • Aldevron
  • Takara Bio
  • Yposkesi
  • Genezen
  • Exthera
  • GenScript ProBio
  • EurekaBio
  • Obio Technology
  • GeneSail Biotech
  • VectorBuilder
  • WuXi ATU
  • Ubrigene
  • Porton Biologics
  • Pharmaron
  • PackGene Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Custom Adeno-Associated Virus (AAV) Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Custom Adeno-Associated Virus (AAV) Services Market Size (2021-2032)
  8. 1.5.1 North America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (2021-2032)
2 Custom Adeno-Associated Virus (AAV) Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Adherent Culture
  3. 2.1.2 Suspension Culture
  4. 2.2 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Type
  5. 2.2.1 Global Custom Adeno-Associated Virus (AAV) Services Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Custom Adeno-Associated Virus (AAV) Services Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Custom Adeno-Associated Virus (AAV) Services Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Regions
  9. 2.3.1 North America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Type (2021-2026)
3 Custom Adeno-Associated Virus (AAV) Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Vaccine Development
  3. 3.1.2 Gene Therapy
  4. 3.1.3 Academic Scientific Research Institution
  5. 3.1.4 Others
  6. 3.2 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Application
  7. 3.2.1 Global Custom Adeno-Associated Virus (AAV) Services Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Custom Adeno-Associated Virus (AAV) Services Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Custom Adeno-Associated Virus (AAV) Services Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Custom Adeno-Associated Virus (AAV) Services Market Size by Regions
  11. 3.3.1 North America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Custom Adeno-Associated Virus (AAV) Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Custom Adeno-Associated Virus (AAV) Services Industry Trends
  2. 4.2 Custom Adeno-Associated Virus (AAV) Services Industry Drivers
  3. 4.3 Custom Adeno-Associated Virus (AAV) Services Industry Opportunities and Challenges
  4. 4.4 Custom Adeno-Associated Virus (AAV) Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Custom Adeno-Associated Virus (AAV) Services Revenue (2021-2026)
  2. 5.2 Global Custom Adeno-Associated Virus (AAV) Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Custom Adeno-Associated Virus (AAV) Services Key Company Headquarters & Area Served
  4. 5.4 Global Custom Adeno-Associated Virus (AAV) Services Company, Product Type & Application
  5. 5.5 Global Custom Adeno-Associated Virus (AAV) Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Custom Adeno-Associated Virus (AAV) Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Custom Adeno-Associated Virus (AAV) Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Custom Adeno-Associated Virus (AAV) Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Lonza
  8. 6.2.1 Lonza Company Information
  9. 6.2.2 Lonza Business Overview
  10. 6.2.3 Lonza Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Lonza Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  12. 6.2.5 Lonza Recent Developments
  13. 6.3 Catalent
  14. 6.3.1 Catalent Company Information
  15. 6.3.2 Catalent Business Overview
  16. 6.3.3 Catalent Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Catalent Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  18. 6.3.5 Catalent Recent Developments
  19. 6.4 Charles River
  20. 6.4.1 Charles River Company Information
  21. 6.4.2 Charles River Business Overview
  22. 6.4.3 Charles River Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Charles River Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  24. 6.4.5 Charles River Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 SK pharmteco
  32. 6.6.1 SK pharmteco Company Information
  33. 6.6.2 SK pharmteco Business Overview
  34. 6.6.3 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 SK pharmteco Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  36. 6.6.5 SK pharmteco Recent Developments
  37. 6.7 Oxford Biomedica
  38. 6.7.1 Oxford Biomedica Company Information
  39. 6.7.2 Oxford Biomedica Business Overview
  40. 6.7.3 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Oxford Biomedica Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  42. 6.7.5 Oxford Biomedica Recent Developments
  43. 6.8 AGC Biologics（MolMed）
  44. 6.8.1 AGC Biologics（MolMed） Company Information
  45. 6.8.2 AGC Biologics（MolMed） Business Overview
  46. 6.8.3 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 AGC Biologics（MolMed） Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  48. 6.8.5 AGC Biologics（MolMed） Recent Developments
  49. 6.9 Gene Universal
  50. 6.9.1 Gene Universal Company Information
  51. 6.9.2 Gene Universal Business Overview
  52. 6.9.3 Gene Universal Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Gene Universal Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  54. 6.9.5 Gene Universal Recent Developments
  55. 6.10 Polyplus (Sartorius)
  56. 6.10.1 Polyplus (Sartorius) Company Information
  57. 6.10.2 Polyplus (Sartorius) Business Overview
  58. 6.10.3 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Polyplus (Sartorius) Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  60. 6.10.5 Polyplus (Sartorius) Recent Developments
  61. 6.11 CCRM
  62. 6.11.1 CCRM Company Information
  63. 6.11.2 CCRM Business Overview
  64. 6.11.3 CCRM Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 CCRM Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  66. 6.11.5 CCRM Recent Developments
  67. 6.12 FUJIFILM Diosynth Biotechnologies
  68. 6.12.1 FUJIFILM Diosynth Biotechnologies Company Information
  69. 6.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
  70. 6.12.3 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 FUJIFILM Diosynth Biotechnologies Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  72. 6.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  73. 6.13 Biovian
  74. 6.13.1 Biovian Company Information
  75. 6.13.2 Biovian Business Overview
  76. 6.13.3 Biovian Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Biovian Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  78. 6.13.5 Biovian Recent Developments
  79. 6.14 Miltenyi Bioindustry
  80. 6.14.1 Miltenyi Bioindustry Company Information
  81. 6.14.2 Miltenyi Bioindustry Business Overview
  82. 6.14.3 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Miltenyi Bioindustry Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  84. 6.14.5 Miltenyi Bioindustry Recent Developments
  85. 6.15 Aldevron
  86. 6.15.1 Aldevron Company Information
  87. 6.15.2 Aldevron Business Overview
  88. 6.15.3 Aldevron Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Aldevron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  90. 6.15.5 Aldevron Recent Developments
  91. 6.16 Takara Bio
  92. 6.16.1 Takara Bio Company Information
  93. 6.16.2 Takara Bio Business Overview
  94. 6.16.3 Takara Bio Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Takara Bio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  96. 6.16.5 Takara Bio Recent Developments
  97. 6.17 Yposkesi
  98. 6.17.1 Yposkesi Company Information
  99. 6.17.2 Yposkesi Business Overview
  100. 6.17.3 Yposkesi Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Yposkesi Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  102. 6.17.5 Yposkesi Recent Developments
  103. 6.18 Genezen
  104. 6.18.1 Genezen Company Information
  105. 6.18.2 Genezen Business Overview
  106. 6.18.3 Genezen Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Genezen Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  108. 6.18.5 Genezen Recent Developments
  109. 6.19 Exthera
  110. 6.19.1 Exthera Company Information
  111. 6.19.2 Exthera Business Overview
  112. 6.19.3 Exthera Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Exthera Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  114. 6.19.5 Exthera Recent Developments
  115. 6.20 GenScript ProBio
  116. 6.20.1 GenScript ProBio Company Information
  117. 6.20.2 GenScript ProBio Business Overview
  118. 6.20.3 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 GenScript ProBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  120. 6.20.5 GenScript ProBio Recent Developments
  121. 6.21 EurekaBio
  122. 6.21.1 EurekaBio Company Information
  123. 6.21.2 EurekaBio Business Overview
  124. 6.21.3 EurekaBio Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 EurekaBio Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  126. 6.21.5 EurekaBio Recent Developments
  127. 6.22 Obio Technology
  128. 6.22.1 Obio Technology Company Information
  129. 6.22.2 Obio Technology Business Overview
  130. 6.22.3 Obio Technology Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Obio Technology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  132. 6.22.5 Obio Technology Recent Developments
  133. 6.23 GeneSail Biotech
  134. 6.23.1 GeneSail Biotech Company Information
  135. 6.23.2 GeneSail Biotech Business Overview
  136. 6.23.3 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 GeneSail Biotech Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  138. 6.23.5 GeneSail Biotech Recent Developments
  139. 6.24 VectorBuilder
  140. 6.24.1 VectorBuilder Company Information
  141. 6.24.2 VectorBuilder Business Overview
  142. 6.24.3 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 VectorBuilder Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  144. 6.24.5 VectorBuilder Recent Developments
  145. 6.25 WuXi ATU
  146. 6.25.1 WuXi ATU Company Information
  147. 6.25.2 WuXi ATU Business Overview
  148. 6.25.3 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 WuXi ATU Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  150. 6.25.5 WuXi ATU Recent Developments
  151. 6.26 Ubrigene
  152. 6.26.1 Ubrigene Company Information
  153. 6.26.2 Ubrigene Business Overview
  154. 6.26.3 Ubrigene Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Ubrigene Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  156. 6.26.5 Ubrigene Recent Developments
  157. 6.27 Porton Biologics
  158. 6.27.1 Porton Biologics Company Information
  159. 6.27.2 Porton Biologics Business Overview
  160. 6.27.3 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Porton Biologics Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  162. 6.27.5 Porton Biologics Recent Developments
  163. 6.28 Pharmaron
  164. 6.28.1 Pharmaron Company Information
  165. 6.28.2 Pharmaron Business Overview
  166. 6.28.3 Pharmaron Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Pharmaron Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  168. 6.28.5 Pharmaron Recent Developments
  169. 6.29 PackGene Biotechnology
  170. 6.29.1 PackGene Biotechnology Company Information
  171. 6.29.2 PackGene Biotechnology Business Overview
  172. 6.29.3 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Revenue, Global Share and Gross Margin (2021-2026)
  173. 6.29.4 PackGene Biotechnology Custom Adeno-Associated Virus (AAV) Services Product Portfolio
  174. 6.29.5 PackGene Biotechnology Recent Developments
7 North America
  1. 7.1 North America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  3. 7.3 North America Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  3. 8.3 Europe Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  3. 10.3 South America Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Custom Adeno-Associated Virus (AAV) Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst